ChinaBio® Consulting is focused exclusively on the life science industry in China. We work with established and emerging biotechnology, medical device and diagnostics companies with operations in China, or seeking to do business in China or with Chinese companies.   Clients have included Pfizer, Roche, LIfe Technologies (Invitrogen/ABI), Genentech, Humana and a number of early and mid-stage China biotechs and pharmas.

ChinaBio® Consulting assists China life science companies with their business strategy, funding and U.S. connections, and we help U.S. companies with their China strategies, competitive analyses, technology searches and China connections. We also assist top tier venture capitalists and investment funds with their China portfolios.  

Here are some examles of how we have helped some of our clients:

Our Clients	Our Services
U.S. Life Science Companies	● China strategy ● Competitive market analysis ● Technology survey/search ● Partnering arrangements ● CRO/CMO selection & management ● China build/operate/transfer
China Life Science Companies	● Business strategy ● Funding assistance ● Partnering arrangements ● Collaboration agreements ● In-licensing/out-licensing ● U.S. operations
Venture Capitalists and Investment Funds	● China strategy ● Investment analysis ● Due diligence ● Portfolio analysis

ChinaBio®  is a highly flexible and collaborative firm that is easy to work with. We structure each engagement to best suit our client’s culture and the specialized needs of the engagement.

If you are a U.S. life science company looking to establish relationships or operations in China, or a China company seeking investors or partners in the U.S., ChinaBio® Consulting has the expertise and talent to help.

For more information, please contact us.